作者: Christina Y. Ha
DOI: 10.1016/J.CGER.2013.10.007
关键词: Intensive care medicine 、 Medicine 、 Therapeutic decision making 、 Immunosuppression 、 Functional status 、 Polypharmacy 、 Comorbidity 、 Inflammatory bowel disease 、 Affect (psychology) 、 Physical therapy 、 Adverse effect
摘要: The medical management of inflammatory bowel disease (IBD) in the older patient extends beyond luminal activity. Factors such as comorbidity, functional status, polypharmacy, and age-related changes physical reserve drug metabolism may affect therapeutic decision making. with IBD is more susceptible to disease-related complications also adverse events therapy, particularly immunosuppression. Appropriate medication selection along multidisciplinary care, factoring not only activity but these risk factors, improve outcomes decrease therapy.